IBDEI0SB ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13278,0)
 ;;=N52.34^^53^589^38
 ;;^UTILITY(U,$J,358.3,13278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13278,1,3,0)
 ;;=3^Erectile Dysfunction Following Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,13278,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,13279,0)
 ;;=N52.39^^53^589^40
 ;;^UTILITY(U,$J,358.3,13279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13279,1,3,0)
 ;;=3^Erectile Dysfunction Post-Surgical
 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,13279,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,13280,0)
 ;;=N52.33^^53^589^39
 ;;^UTILITY(U,$J,358.3,13280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13280,1,3,0)
 ;;=3^Erectile Dysfunction Following Urethral Surgery
 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,13280,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,13281,0)
 ;;=N52.32^^53^589^36
 ;;^UTILITY(U,$J,358.3,13281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13281,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,13281,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,13282,0)
 ;;=N52.31^^53^589^37
 ;;^UTILITY(U,$J,358.3,13282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13282,1,3,0)
 ;;=3^Erectile Dysfunction Following Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,13282,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,13282,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,13283,0)
 ;;=N52.2^^53^589^43
 ;;^UTILITY(U,$J,358.3,13283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13283,1,3,0)
 ;;=3^Erectile Dysfunction,Drug-Induced
 ;;^UTILITY(U,$J,358.3,13283,1,4,0)
 ;;=4^N52.2
 ;;^UTILITY(U,$J,358.3,13283,2)
 ;;=^5015756
 ;;^UTILITY(U,$J,358.3,13284,0)
 ;;=N52.03^^53^589^34
 ;;^UTILITY(U,$J,358.3,13284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13284,1,3,0)
 ;;=3^Erectile Dysfunction Comb Artrl Insuff & Corporo-Venous Occlusv
 ;;^UTILITY(U,$J,358.3,13284,1,4,0)
 ;;=4^N52.03
 ;;^UTILITY(U,$J,358.3,13284,2)
 ;;=^5015754
 ;;^UTILITY(U,$J,358.3,13285,0)
 ;;=N52.02^^53^589^35
 ;;^UTILITY(U,$J,358.3,13285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13285,1,3,0)
 ;;=3^Erectile Dysfunction Corporo-Venous Occlusive
 ;;^UTILITY(U,$J,358.3,13285,1,4,0)
 ;;=4^N52.02
 ;;^UTILITY(U,$J,358.3,13285,2)
 ;;=^5015753
 ;;^UTILITY(U,$J,358.3,13286,0)
 ;;=N52.1^^53^589^42
 ;;^UTILITY(U,$J,358.3,13286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13286,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,13286,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,13286,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,13287,0)
 ;;=N52.01^^53^589^41
 ;;^UTILITY(U,$J,358.3,13287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13287,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,13287,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,13287,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,13288,0)
 ;;=N95.2^^53^589^81
 ;;^UTILITY(U,$J,358.3,13288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13288,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,13288,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,13288,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,13289,0)
 ;;=R30.9^^53^589^65
 ;;^UTILITY(U,$J,358.3,13289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13289,1,3,0)
 ;;=3^Micturition Painful,Unspec
 ;;^UTILITY(U,$J,358.3,13289,1,4,0)
 ;;=4^R30.9
 ;;^UTILITY(U,$J,358.3,13289,2)
 ;;=^5019324
 ;;^UTILITY(U,$J,358.3,13290,0)
 ;;=R30.0^^53^589^26
 ;;^UTILITY(U,$J,358.3,13290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13290,1,3,0)
 ;;=3^Dysuria
